A Study to Evaluate the Efficacy and Safety of BR1017A and BR1017B Combination Therapy in Essential Hypertension Patients With Primary Hypercholesterolemia
Conditions:   Essential Hypertension;   Primary Hypercholesterolemia Interventions:   Drug: Fimasartan;   Drug: Ezetimibe/Atorvastatin;   Drug: Fimasartan Placebo;   Drug: Ezetimibe/Atorvastatin Placebo Sponsor:   Boryung Pharmaceutical Co., Ltd Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 5, 2023 Category: Research Source Type: clinical trials

A Phase III Confirmatory Study of K-877 (Pemafibrate) in Patients With Hypercholesterolemia and Statin Intolerance
Condition:   Hypercholesterolemia Interventions:   Drug: K-877 0.2 mg/day (once daily);   Drug: K-877 0.4 mg/day (once daily);   Drug: Placebo (once daily) Sponsor:   Kowa Company, Ltd. Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 28, 2023 Category: Research Source Type: clinical trials